Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (2mg + 0.3mg + 1000mg) Technical Specification:
| Product Name: | Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets |
| Brand Name: | Generic |
| Strength: | (0.5mg + 0.2mg + 500mg), (1mg + 0.2mg + 500mg), (1mg + 0.3mg + 500mg), (1mg + 0.2mg + 1000mg), (1mg + 0.3mg + 1000mg), (2mg + 0.2mg + 500mg), (2mg + 0.3mg + 500mg), (2mg + 0.2mg + 1000mg), (2mg + 0.3mg + 1000mg), (3mg + 0.3mg + 500mg), (3mg + 0.3mg + 1000mg) |
| Dosage Form: | Tablet (Uncoated Bilayer) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 15s, 100s, 150s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Anti-diabetic, Hypoglycaemic |
| Indication: | To treat type 2 Diabetes Mellitus |
| Storage: | Store below 30°C. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (0.5mg + 0.2mg + 500mg)
Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (1mg + 0.2mg + 500mg)
Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (1mg + 0.3mg + 500mg)
Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (1mg + 0.2mg + 1000mg)
Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (1mg + 0.3mg + 1000mg)
Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (2mg + 0.2mg + 500mg)
Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (2mg + 0.3mg + 500mg)
Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (2mg + 0.2mg + 1000mg)
Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (2mg + 0.3mg + 1000mg)
Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (3mg + 0.3mg + 500mg)
Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (3mg + 0.3mg + 1000mg)
QUALITATIVE AND QUANTITATIVE COMPOSITION:
A. Glimepiride, Voglibose and Metformin Hydrochloride (SR) Tablets (2mg + 0.3mg + 1000mg)
Each Uncoated Bilayered Tablet Contains:
Glimepiride IP…………………………………….2mg
Voglibose IP……………………………….………0.3mg
Metformin Hydrochloride IP……………….1000mg
(As Sustained-release form)
Excipients………………………………………..……Q.S.
Colour: Lake Quinoline yellow (In Glimepiride & Voglibose Layer)
THERAPEUTIC INDICATIONS:
This combination is used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
CAUTION & SCHEDULE:
CAUTION:
Keep medicine out of reach of children.
Do not Crush or Chew the Tablet. Swallow the whole Tablet with water.
SCHEDULE:
SCHEDULE H PRESCRIPTION DRUG: WARNING: TO BE SOLD BY RETAIL ON THE PRESCRIPTION OF A registered medical practitioner ONLY.
SCHEDULE G PRESCRIPTION DRUG: CAUTION: it is dangerous to take this preparation except under medical supervision.
STORAGE & DOSAGE:
STORAGE: Store in cool & dry place at a temperature not exceeding 30°C. Protect from light and moisture.
DOSAGE: As directed by the Physician.